Lundbeckfonden Ventures

Lundbeckfonden Ventures is a Copenhagen-based evergreen life science venture fund, wholly owned by the Lundbeck Foundation. Established in the autumn of 2009, its unique structure as a foundation-backed entity provides a long-term investment horizon, distinguishing it from traditional venture capital funds with fixed fund cycles. This allows for patient capital deployment aimed at fostering significant advancements in the life science sector, aligning with the foundation's broader philanthropic mission to improve brain health.

The fund primarily targets early-stage and growth-stage companies within therapeutics, medical devices, and digital health. While headquartered in Denmark, its investment scope is international, with a strong focus on opportunities across Europe and North America. Lundbeckfonden Ventures actively seeks to co-invest with other reputable venture capital firms, leveraging syndication to provide robust financial backing and strategic support to its portfolio companies. Their evergreen nature enables them to commit to longer-term partnerships, supporting companies through multiple financing rounds as they progress from preclinical development to commercialization.

Lundbeckfonden Ventures typically deploys initial investments ranging from approximately $1.08 million (€1 million) to $5.4 million (€5 million). Over the lifetime of an investment, their total commitment to a single company can extend up to $16.2 million (€15 million), reflecting their dedication to supporting portfolio companies through various growth stages. Beyond capital, the fund offers deep industry expertise, access to a broad network within the pharmaceutical and biotech sectors, and strategic guidance, aiming to accelerate the development and market entry of innovative life science solutions.